{"id":9884,"date":"2026-07-08T16:30:00","date_gmt":"2026-07-08T22:30:00","guid":{"rendered":"https:\/\/www.podermexico.mx\/?p=9884"},"modified":"2026-07-08T14:08:33","modified_gmt":"2026-07-08T20:08:33","slug":"vertex-pharmaceuticals-adquiere-crinetics-por-8-8-mil-millones-de-dolares-para-expandir-su-portafolio-de-enfermedades-raras","status":"publish","type":"post","link":"https:\/\/www.podermexico.mx\/?p=9884","title":{"rendered":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">La firma Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por <strong>$8,800 millones de d\u00f3lares<\/strong> netos, marcando la mayor adquisici\u00f3n en su historia para reducir la dependencia de su franquicia de fibrosis qu\u00edstica. El cierre de la transacci\u00f3n est\u00e1 programado para el tercer trimestre de <strong>2026<\/strong>, sujeto a las autorizaciones regulatorias y la ratificaci\u00f3n de los accionistas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Con este movimiento, Vertex incorpora Palsonify, un tratamiento oral aprobado por la FDA y la EMA para la acromegalia, trastorno que afecta a unas <strong>20 mil<\/strong> personas en Estados Unidos. Tambi\u00e9n adquiere atumelnant, un f\u00e1rmaco en fase 3 de desarrollo para la hiperplasia suprarrenal cong\u00e9nita, condici\u00f3n que cuenta con <strong>17 mil<\/strong> pacientes potenciales en dicho mercado. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La farmac\u00e9utica prev\u00e9 que ambos activos generen ingresos conjuntos superiores a los <strong>$5 mil millones de d\u00f3lares<\/strong> anuales en su punto m\u00e1ximo y que la operaci\u00f3n impulse el ingreso operativo ajustado en 2029.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La oferta de <strong>$85 d\u00f3lares<\/strong> por acci\u00f3n represent\u00f3 una prima del <strong>102%<\/strong> sobre el valor de cotizaci\u00f3n de Crinetics. Para financiar la adquisici\u00f3n, Vertex combinar\u00e1 sus reservas de efectivo actuales con una l\u00ednea de cr\u00e9dito puente de <strong>$4,500 millones de d\u00f3lares<\/strong> respaldada por Bank of America y Morgan Stanley.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La firma Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos, marcando la mayor adquisici\u00f3n en su historia para reducir la dependencia de su franquicia de fibrosis qu\u00edstica. El cierre de la transacci\u00f3n est\u00e1 programado para el tercer trimestre de 2026, sujeto a las autorizaciones regulatorias y la ratificaci\u00f3n de los accionistas. Con este movimiento, Vertex &hellip;<\/p>\n","protected":false},"author":7,"featured_media":9885,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[60],"tags":[2466,2465],"class_list":["post-9884","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-empresas","tag-crinetics","tag-vertex-pharmaceuticals"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Poder M\u00e9xico\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.podermexico.mx\/?p=9884\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_MX\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Poder M\u00e9xico - Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\u00e9xico\" \/>\n\t\t<meta property=\"og:description\" content=\"Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.podermexico.mx\/?p=9884\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-07-08T22:30:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-07-08T20:08:33+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\u00e9xico\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#blogposting\",\"name\":\"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\\u00e9xico\",\"headline\":\"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\\u00f3lares para expandir su portafolio de enfermedades raras\",\"author\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/VERTEX.jpg\",\"width\":1000,\"height\":666},\"datePublished\":\"2026-07-08T16:30:00-06:00\",\"dateModified\":\"2026-07-08T14:08:33-06:00\",\"inLanguage\":\"es-MX\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#webpage\"},\"articleSection\":\"Empresas y Negocios, Crinetics, Vertex Pharmaceuticals\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.podermexico.mx\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=60#listItem\",\"name\":\"Empresas y Negocios\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=60#listItem\",\"position\":2,\"name\":\"Empresas y Negocios\",\"item\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=60\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#listItem\",\"name\":\"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\\u00f3lares para expandir su portafolio de enfermedades raras\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#listItem\",\"position\":3,\"name\":\"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\\u00f3lares para expandir su portafolio de enfermedades raras\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=60#listItem\",\"name\":\"Empresas y Negocios\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\",\"name\":\"Poder M\\u00e9xico\",\"description\":\"Donde los l\\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\\u00edtica y los negocios\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7\",\"name\":\"Poder M\\u00e9xico\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6873d270747c7f511ab0e491b4ef59ff185c68a5912118c90f83cdcd498e434b?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Poder M\\u00e9xico\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#webpage\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884\",\"name\":\"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\\u00e9xico\",\"description\":\"Vertex Pharmaceuticals acord\\u00f3 la compra de Crinetics por $8,800 millones de d\\u00f3lares netos\",\"inLanguage\":\"es-MX\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/VERTEX.jpg\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884\\\/#mainImage\",\"width\":1000,\"height\":666},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=9884#mainImage\"},\"datePublished\":\"2026-07-08T16:30:00-06:00\",\"dateModified\":\"2026-07-08T14:08:33-06:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#website\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/\",\"name\":\"Poder M\\u00e9xico\",\"description\":\"Donde los l\\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\\u00edtica y los negocios\",\"inLanguage\":\"es-MX\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\u00e9xico","description":"Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos","canonical_url":"https:\/\/www.podermexico.mx\/?p=9884","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.podermexico.mx\/?p=9884#blogposting","name":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\u00e9xico","headline":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras","author":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"publisher":{"@id":"https:\/\/www.podermexico.mx\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.podermexico.mx\/wp-content\/uploads\/2026\/07\/VERTEX.jpg","width":1000,"height":666},"datePublished":"2026-07-08T16:30:00-06:00","dateModified":"2026-07-08T14:08:33-06:00","inLanguage":"es-MX","mainEntityOfPage":{"@id":"https:\/\/www.podermexico.mx\/?p=9884#webpage"},"isPartOf":{"@id":"https:\/\/www.podermexico.mx\/?p=9884#webpage"},"articleSection":"Empresas y Negocios, Crinetics, Vertex Pharmaceuticals"},{"@type":"BreadcrumbList","@id":"https:\/\/www.podermexico.mx\/?p=9884#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx#listItem","position":1,"name":"Home","item":"https:\/\/www.podermexico.mx","nextItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=60#listItem","name":"Empresas y Negocios"}},{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=60#listItem","position":2,"name":"Empresas y Negocios","item":"https:\/\/www.podermexico.mx\/?cat=60","nextItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?p=9884#listItem","name":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?p=9884#listItem","position":3,"name":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras","previousItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=60#listItem","name":"Empresas y Negocios"}}]},{"@type":"Organization","@id":"https:\/\/www.podermexico.mx\/#organization","name":"Poder M\u00e9xico","description":"Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","url":"https:\/\/www.podermexico.mx\/"},{"@type":"Person","@id":"https:\/\/www.podermexico.mx\/?author=7#author","url":"https:\/\/www.podermexico.mx\/?author=7","name":"Poder M\u00e9xico","image":{"@type":"ImageObject","@id":"https:\/\/www.podermexico.mx\/?p=9884#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/6873d270747c7f511ab0e491b4ef59ff185c68a5912118c90f83cdcd498e434b?s=96&d=mm&r=g","width":96,"height":96,"caption":"Poder M\u00e9xico"}},{"@type":"WebPage","@id":"https:\/\/www.podermexico.mx\/?p=9884#webpage","url":"https:\/\/www.podermexico.mx\/?p=9884","name":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\u00e9xico","description":"Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos","inLanguage":"es-MX","isPartOf":{"@id":"https:\/\/www.podermexico.mx\/#website"},"breadcrumb":{"@id":"https:\/\/www.podermexico.mx\/?p=9884#breadcrumblist"},"author":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"creator":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.podermexico.mx\/wp-content\/uploads\/2026\/07\/VERTEX.jpg","@id":"https:\/\/www.podermexico.mx\/?p=9884\/#mainImage","width":1000,"height":666},"primaryImageOfPage":{"@id":"https:\/\/www.podermexico.mx\/?p=9884#mainImage"},"datePublished":"2026-07-08T16:30:00-06:00","dateModified":"2026-07-08T14:08:33-06:00"},{"@type":"WebSite","@id":"https:\/\/www.podermexico.mx\/#website","url":"https:\/\/www.podermexico.mx\/","name":"Poder M\u00e9xico","description":"Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","inLanguage":"es-MX","publisher":{"@id":"https:\/\/www.podermexico.mx\/#organization"}}]},"og:locale":"es_MX","og:site_name":"Poder M\u00e9xico - Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","og:type":"article","og:title":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\u00e9xico","og:description":"Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos","og:url":"https:\/\/www.podermexico.mx\/?p=9884","article:published_time":"2026-07-08T22:30:00+00:00","article:modified_time":"2026-07-08T20:08:33+00:00","twitter:card":"summary_large_image","twitter:title":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras - Poder M\u00e9xico","twitter:description":"Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos"},"aioseo_meta_data":{"post_id":"9884","title":null,"description":"Vertex Pharmaceuticals acord\u00f3 la compra de Crinetics por $8,800 millones de d\u00f3lares netos","keywords":null,"keyphrases":{"focus":{"keyphrase":"Crinetics","score":100,"analysis":{"keyphraseInTitle":{"score":9,"maxScore":9,"error":0},"keyphraseInDescription":{"score":9,"maxScore":9,"error":0},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInIntroduction":{"score":9,"maxScore":9,"error":0},"keyphraseInSubHeadings":[],"keyphraseInImageAlt":[],"keywordDensity":{"type":"best","score":9,"maxScore":9,"error":0}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-07-08 20:08:33","updated":"2026-07-09 13:52:41","seo_analyzer_scan_date":null,"focus_keyword":"Crinetics","additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.podermexico.mx\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.podermexico.mx\/?cat=60\" title=\"Empresas y Negocios\">Empresas y Negocios<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tVertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.podermexico.mx"},{"label":"Empresas y Negocios","link":"https:\/\/www.podermexico.mx\/?cat=60"},{"label":"Vertex Pharmaceuticals adquiere Crinetics por $8.8 mil millones de d\u00f3lares para expandir su portafolio de enfermedades raras","link":"https:\/\/www.podermexico.mx\/?p=9884"}],"_links":{"self":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/9884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9884"}],"version-history":[{"count":1,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/9884\/revisions"}],"predecessor-version":[{"id":9886,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/9884\/revisions\/9886"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/media\/9885"}],"wp:attachment":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}